Search Results for "John Flygare Genentech Contact"
Original Source: SMi's ADC Summit
This new and exciting event will present attendees with an in-depth view into novel innovations, developments and utilities of antibody-drug conjugates.
Matching Channels
Matching News
Partnering with Genentech: Pioneering partnerships
Genentech is a top biotech company, subsidiary of Swiss pharma giant Roche, and active in partnering, licensing in, biotech healthcare. Genentech has an active partnering group that recognizes the sig...
Ensemble, Genentech in discovery deal
Ensemble Therapeutics Corp. (Cambridge, Mass.) partnered with Genentech Inc. to use Ensemblin drug discovery technology to discover macrocyclic drug candidates against undisclosed targets chosen by Ge...
Genentech is the biotech subsidiary of Roche. View Roche glossary profile for further detailsThe post Genentech appeared first on .
Ensemble, Genentech sign drug discovery collaboration
Ensemble Therapeutics, a biotechnology company, and Genentech, a member of the Roche Group, have entered into a collaboration to discover macrocyclic drug candidates against Genentech's biological tar...
Table: Roche/Genentech CNS pipeline
Contrarian thinking Roche/Genentech CNS pipeline Roche (SIX:ROG; OTCQX:RHHBY) and its Genentech Inc. unit have disclosed 11 compounds in clinical development for CNS diseases. Through Phase II, molecu...
Genentech Partnering - Bringing the best science into Genentech
In this episode of PharmaTelevision News Review, filmed in Amsterdam at BioEurope Spring 2012, Fintan walton talks to Tom Zioncheck, Senior Director of Business Development at Genentech Partnering
NCM to collaborate with Genentech for PET radiopharmaceutical
PET radiopharmaceutical developer NCM USA has signed a technology development and supply agreement with Genentech. From its New York City-based manufacturing site, NCM will supply PET radiopharmaceuti...
Roche Taps Scientific Heavyweight John Reed To Head Early Pharma R&D
Roche has enlisted John Reed - head of the La Jolla-based Sanford-Burnham Medical Research Institute - to lead the Swiss group’s non-Genentech pharmaceutical R&D efforts.
Matching PubMed Articles
Introduction for the Special Issue on Glycosylation and Immunity.
Disaster care: children of hurricane katrina.
Six years later, mental health effects are still evident in Gulf Coast children.
C-H···π Interactions in the CHBrF(2)···HCCH Weakly Bound Dimer.
The microwave spectra of four isotopologues of the CHBrF(2)···HCCH weakly bound dimer have been measured in the 6-18 GHz region using chirped-pulse and Balle-Flygare Fourier-transform microwave spe...
Ralph m. Steinman (1943-2011).
Changing End Points in Breast-Cancer Drug Approval - The Avastin Story.
In December 2007, the Oncologic Drugs Advisory Committee (ODAC) of the Food and Drug Administration (FDA) met to discuss the risks and benefits of Genentech's Avastin (bevacizumab) for use in combinat...
